What Happened?
Biogen Idec hired Bobby Narasimham as Director-CyberSecurity Operations
Date of management change: September 27, 2012
Biogen Idec hired Bobby Narasimham as Director-CyberSecurity Operations
We are a global biotechnology company, specializing in discovering, developing, and delivering innovative therapies for the treatment of neurodegenerative, non-malignant hematologic and autoimmune diseases to patients worldwide. As a company, we are focused on cutting-edge science and medicines that address unmet patient needs and change the course of these devastating diseases. Founded in 1978, we are the world`s oldest independent biotechnology company and take pride in being known for pioneering the development of leading multiple sclerosis therapies. With approximately 7,000 employees worldwide, we are focused on better understanding the underlying biology of diseases so we can discover and deliver innovative treatments that make a real difference in the lives of patients. We also put great focus on being good corporate citizens. Our commitment to corporate citizenship extends to patient education and support programs, giving back to the communities in which we operate, promoting and advancing science education, and operating in a sustainable manner. These cultural imperatives are directly incorporated into our business activities.
Bobby Narasimham is Director-CyberSecurity Operations at Biogen Idec
News
Other IT executives who recently changed jobs as well: Contis Didier, Wood Christal, Broddle Daryl, Lyons Timothy, Gasster Elizabeth, Kluempke Gary, Campbell Wayne, Felder Mitchell, Radhakrishnan Rashmi, Finnelle Christine, O`Connor Daniel
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.